Skip to main content
Intensified head and neck cancer treatments yield varied results
11/9/2018

People with locally advanced head and neck squamous cell carcinoma who received cetuximab and radiotherapy with concurrent chemotherapy had 27% reduced odds of disease progression or death, compared with those who were given cisplatin and radiotherapy, according to a study in the Journal of Clinical Oncology. However, another study in the same journal showed similar progression-free survival among those who received induction carboplatin-based chemotherapy with cetuximab and radiotherapy and those who underwent standard chemoradiotherapy alone.

Full Story: